These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25006678)

  • 1. Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial.
    Dreyer G; Tucker AT; Harwood SM; Pearse RM; Raftery MJ; Yaqoob MM
    PLoS One; 2014; 9(7):e99461. PubMed ID: 25006678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
    Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
    Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
    J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ergocalciferol improves endothelial vasodilatory and vasoconstrictor function in an in vivo model of mild uraemia.
    Dreyer G; Kieswich J; Harwood S; Ahluwalia A; Yaqoob MM
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31789348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate?
    Qunibi WY; Abdellatif A; Sankar S; Hamdan Z; Lin FY; Ingle J; Cadena A; Gelfond J; Kasinath B
    Clin Nephrol; 2010 Apr; 73(4):276-85. PubMed ID: 20353735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Vitamin D on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Borgi L; McMullan C; Wohlhueter A; Curhan GC; Fisher ND; Forman JP
    Am J Hypertens; 2017 Feb; 30(2):124-129. PubMed ID: 28077419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women.
    Mueangpaisarn P; Chaiamnuay S
    Aging Clin Exp Res; 2020 Jan; 32(1):41-48. PubMed ID: 30784012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial.
    Lundwall K; Jörneskog G; Jacobson SH; Spaak J
    Am J Nephrol; 2015; 42(4):265-73. PubMed ID: 26496210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial.
    Shroff R; Wan M; Gullett A; Ledermann S; Shute R; Knott C; Wells D; Aitkenhead H; Manickavasagar B; van't Hoff W; Rees L
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):216-23. PubMed ID: 22266572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients.
    Agarwal G; Hirachan P; Gelfond J; Fanti P; Hura C; Bansal S
    BMC Nephrol; 2016 Oct; 17(1):144. PubMed ID: 27717322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vitamin D deficiency within a large integrated health care delivery system.
    Stratton-Loeffler MJ; Lo JC; Hui RL; Coates A; Minkoff JR; Budayr A
    J Manag Care Pharm; 2012 Sep; 18(7):497-505. PubMed ID: 22971203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial.
    Miskulin DC; Majchrzak K; Tighiouart H; Muther RS; Kapoian T; Johnson DS; Weiner DE
    J Am Soc Nephrol; 2016 Jun; 27(6):1801-10. PubMed ID: 26677862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional vitamin D supplementation in dialysis: a randomized trial.
    Bhan I; Dobens D; Tamez H; Deferio JJ; Li YC; Warren HS; Ankers E; Wenger J; Tucker JK; Trottier C; Pathan F; Kalim S; Nigwekar SU; Thadhani R
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):611-9. PubMed ID: 25770176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients.
    Shah N; Bernardini J; Piraino B
    Perit Dial Int; 2005; 25(4):362-6. PubMed ID: 16022093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of vitamin D repletion regimens to correct vitamin D status in adults.
    Pepper KJ; Judd SE; Nanes MS; Tangpricha V
    Endocr Pract; 2009 Mar; 15(2):95-103. PubMed ID: 19342361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome.
    Sansanayudh N; Wongwiwatthananukit S; Phetkrajaysang N; Krittiyanunt S
    Int J Clin Pharm; 2014 Aug; 36(4):771-8. PubMed ID: 24853094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients.
    Agarwal G; Vasquez K; Penagaluru N; Gelfond J; Qunibi WY
    Hemodial Int; 2015 Oct; 19(4):499-508. PubMed ID: 25790374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.